February 28, 2024
29/02/2024
February 28, 2024
LA JOLLA, CA Molecules often have a structural asymmetry called chirality, which means they can appear in alternative, mirror-image versions, akin to the left and right versions of human hands. One of the great mysteries about the origins of life on Earth is that virtually all of the fundamental molecules of biology, such as the building blocks of proteins and DNA, appear in just one chiral form.
Scripps Research chemists, in two high-profile studies, have now proposed an elegant solution to this mystery, showing how this single-handedness or homochirality could have become established in biology.
The studies were published in the Proceedings of the National Academy of Sciences on February 5, 2024, and in Nature on February 28, 2024. Together, they suggest that the emergence of homochirality was due largely to a chemistry phenomenon called kinetic resolution, in which one chiral form becomes more abundant than another due to faster production and/or slower depletion.
There have been many proposals for how homochirality emerged in specific molecules specific amino acids, for example but we really have needed a more general theory, says Donna Blackmond, PhD, professor and John C. Martin Chair in the Department of Chemistry at Scripps Research, who led both studies.
Graduate student Jinhan Yu and postdoctoral research associate Min Deng, PhD, were the first authors of the two studies.
The conundrum of homochirality
Origin of life chemistry has been a busy field for much of the past century. Its practitioners have discovered dozens of key reactions that plausibly occurred on the early, prebiotic Earth to produce the first DNAs, RNAs, sugars, amino acids and other molecules that sustain life. Missing from this body of work, however, has been a plausible prebiotic theory for the emergence of homochirality.
There has been a tendency in the field to ignore the chirality issue when looking for plausible reactions that could have made the first biological molecules, Blackmond says. It's frustrating, because without reactions that favor homochirality, we wouldnt have life.
Ordinary chemical reactions that produce chiral molecules tend to yield equal ( racemic ) mixes of left- and right-handed forms. Outside of biology, this mixing typically doesn't matter, as both forms usually have similar or identical properties. Within biology, though, as a consequence of extensive homochirality, it is commonly the case that only the left- or the right-handed form of a chiral molecule has useful properties the other may be inert or even toxic. Thus, cells often guide reactions to yield specific chiral forms, using highly evolved enzymes.
The prebiotic Earth would not have had such enzymes, though so how did homochirality ever arise?
A paradoxical result
In their study in Proceedings of the National Academy of Sciences, Blackmond and her team addressed this problem for amino acids. These small organic molecules are used as building blocks for proteins by all living things on Earth, but exist in biology in just the left-handed chiral form.
The researchers specifically sought to reproduce homochirality in a central process in amino acid production called transamination, by using a relatively simple, plausibly prebiotic chemistry that excludes complex enzymes.
In early tests, the team's experimental reaction worked, and yielded amino acids that were enriched for one chiral form versus the other. The problem was that the favored form was the right-handed form the one that biology doesn't use.
We were stuck for a while, but then the light bulb went on we realized we could do part of the reaction in reverse, Blackmond says.
When they did that, the reaction no longer preferentially made right-handed amino acids. In a striking example of kinetic resolution, it instead preferentially consumed and depleted the right-handed versions leaving more of the desired left-handed amino acids. It thus served as a plausible route to homochirality for amino acids used in living cells.
Tying it all together
For the Nature study, the chemists explored a simple reaction with which amino acids in the earliest life forms might have been linked together into the first short proteins (also known as peptides). The reaction had been published earlier by another researcher, but had never been investigated for its ability to produce homochiral peptides from racemic or near-racemic mixes of amino acids.
Once again, the chemists ran into what seemed to be an insurmountable obstacle: They discovered that in forming peptide chains of amino acids, the reaction worked faster for linkages of left-handed with right-handed amino acids the opposite of the desired homochiral peptides.
Still, the team persevered. Ultimately, they discovered that when one type of amino acid in the starting pool of amino acids had even a moderate dominance of the left-handed form as their other study made plausible the faster reaction rate for left-handed-to-right-handed linkages preferentially depleted right-handed amino acids, leaving an ever-greater concentration of left-handed ones. Additionally, the left-right-left-right peptides had a stronger tendency to clump together and fall out of solution as solids. These kinetic resolution-related phenomena thus ended up yielding a surprisingly pure solution of almost fully left-handed peptides.
To Blackmond, the seemingly paradoxical mechanisms uncovered in these studies offer the first convincing and broad explanation for the emergence of homochirality an explanation that probably works not only for amino acids, she says, but also for other fundamental molecules of biology such as DNA and RNA.
Prebiotic access to enantioenriched amino aci
LINK: | https://www.scripps.edu/news-and-events/press-room/2024/20240228-black... |
See more stories from scripps |
More from Scripps
19/11/2024
November 19, 2024
Scripps Research scientists make annual Highly Cited Researchers list Featured scientists represent a wide range of fields including chemistry, microbiology, im...
30/10/2024
October 30, 2024
Calibr-Skaggs announces initial dosing of a first-in-class regenerative lung medicine in a phase 1 trial for idiopathic pulmonary fibrosis CMR316 is a once-week...
24/10/2024
October 23, 2024
Human mini-brains reveal autism biology and potential treatments By creating personalized brain organoids in the lab, Scripps Research scientists showed how ...
16/10/2024
October 15, 2024
Scripps Research scientists discover chemical probes for previously undruggable cancer target Scientists uncover how small molecules interact with a cancer-re...
02/10/2024
October 01, 2024
Professor Stuart Lipton awarded $5 million to study the chemical biology of air pollution on the human brain The grant from the NIA/NIH will support research in...
01/10/2024
September 30, 2024
Seeing double: Designing drugs that target twin cancer proteins Scripps Research scientists used knowledge about a protein to characterize drugs that selectiv...
27/09/2024
September 25, 2024
Scripps Research scientist Ilia Droujinine receives over $3 million to reveal the body's interorgan networks The awards from the NIDDK and the LLHF will let...
20/09/2024
September 19, 2024
Genetic tracing at the Huanan Seafood market further supports COVID animal origins An international collaboration between Scripps Research, University of Arizon...
12/09/2024
September 11, 2024
Scripps Research scientists expand the genetic alphabet to create new proteins The novel method uses sets of four RNA nucleotides rather than the natural three ...
27/08/2024
August 26, 2024
New way to potentially slow cancer growth Using a combination of two protein-mapping methods, Scripps Research scientists uncover novel proteins that could be t...
22/08/2024
August 21, 2024
Gut molecule slows fat burning during fasting Scripps Research scientists discovered a molecule produced by roundworm intestines that signals the brain to slow ...
14/08/2024
March 11, 2024
Using wrist-worn activity trackers to help patients reduce long COVID symptoms New Scripps Research trial aims to validate the use of wearables in guiding parti...
09/08/2024
August 08, 2024
Scripps Research chemists develop new sustainable reaction for creating unique molecular building blocks The building blocks can be used to create polymers with...
26/07/2024
July 25, 2024
Timing matters: Scripps Research study shows ways to improve health alerts Wearable health sensors are a powerful tool in disease detection and in stemming the ...
17/07/2024
July 16, 2024
New sleep study aims to understand cognitive decline in women Scripps Research launches digital trial to identify sleep-related risk factors for Alzheimer's...
11/07/2024
July 09, 2024
Researchers identify brain region involved in oxycodone relapse Study by Scripps Research scientists suggests future therapies for opioid and alcohol addiction....
11/07/2024
July 10, 2024
Researchers pinpoint brain cells that delay first bite of food A set of neurons identified by Scripps Research scientists influence the start of eating and drin...
09/07/2024
July 08, 2024
Nine new faculty join Scripps Research The newly appointed faculty are making transformative discoveries in areas ranging across drug discovery, neuroscience, c...
04/07/2024
May 21, 2024
Drug-like inhibitor shows promise in preventing flu Scripps Research scientists have developed a potential drug-like molecule that blocks the first stage of typ...
03/07/2024
July 02, 2024
Advancing toward a preventative HIV vaccine Across four preclinical studies, Scripps Research, IAVI, and additional collaborators make headway in stimulating th...
21/06/2024
June 20, 2024
Neuroscientist Xin Jin granted Pew and McKnight awards Jin is named a 2024 Pew Scholar and receives the McKnight Scholar Award, supporting her research in mappi...
04/06/2024
June 03, 2024
Esteemed life sciences attorney Barbara Kosacz joins Scripps Research Board of Directors June 03, 2024 LA JOLLA, CA Scripps Research's vision to translat...
24/05/2024
May 23, 2024
Scripps Research's Skaggs Graduate School awards doctoral degrees to 32nd graduating class Skaggs family also honored at commencement ceremony as first reci...
23/05/2024
May 22, 2024
Scripps Research scientists uncover new molecular drivers of Alzheimer's By recording detailed electrical and protein measurements of individual brain cell...
21/05/2024
May 20, 2024
New method to reveal what drives brain diseases Scripps Research scientists develop CRISPR screen technology to determine disease mechanism from tissues with ac...
20/05/2024
May 17, 2024
Scripps Research chemists develop new method for making gamma chiral centers on simple carboxylic acids C-H activation-based method should speed drug molecule ...
17/05/2024
May 16, 2024
Scripps Research chemist Donna Blackmond elected to the Royal Society of the U.K. Blackmond's wide-ranging work has shaped origin of life theories, our unde...
08/05/2024
May 07, 2024
Professor emeritus John (Jack) Johnson elected to the National Academy of Sciences Johnson's multi-disciplinary research has been instrumental in shaping ou...
03/05/2024
May 02, 2024
TIME100 Health list features Scripps Research Executive Vice President Eric Topol New list honors 100 individuals who most influenced global health in 2024. M...
02/05/2024
May 01, 2024
New technique improves T cell-based immunotherapies for solid tumors Scripps Research scientists help T cells more effectively kill solid tumors cells in vitro ...
20/04/2024
April 19, 2024
New copper-catalyzed C-H activation strategy from Scripps Research Two-mode reactions inspired by human detox enzymes offer powerful new tools for drug discover...
12/04/2024
April 11, 2024
Scripps Research study reveals new approach for combating resting bacteria Blocking long phosphate molecules could eventually help treat chronic infections in...
06/04/2024
April 05, 2024
A simple, inexpensive way to make carbon atoms bind together A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules,...
04/04/2024
April 03, 2024
Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first...
30/03/2024
March 29, 2024
How blocking a neural receptor responsible for addiction could reduce alcohol use A Scripps Research team found that a new therapeutic that targets the kappa op...
13/03/2024
March 13, 2024
New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...
29/02/2024
February 29, 2024
Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...
29/02/2024
February 28, 2024
How molecular handedness emerged in early biology Scripps Research chemists fill a major gap in origin-of-life theories. February 28, 2024 LA JOLLA, CA Mole...
22/02/2024
February 21, 2024
Snaking toward a universal antivenom Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. February 21, 2024 ...
06/02/2024
February 06, 2024
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases AbbVie...
26/01/2024
January 25, 2024
Re-energizing mitochondria to treat Alzheimer's disease Scripps Research team restored neuron-to-neuron connections in human cells. January 25, 2024 LA JO...
24/01/2024
January 04, 2024
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health For the last century, institute leaders and renowned scie...
23/01/2024
January 23, 2024
New technology lets researchers track brain cells' off switches The method could shed light on what goes awry in numerous brain conditions when neurons ar...
09/01/2024
January 08, 2024
Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines The ALSAM Foundation, founded by the Skaggs family, provides lasting g...
04/01/2024
January 03, 2024
Life science entrepreneur Gene Lay joins Scripps Research Board of Directors Lay, founder of the global biotech company BioLegend, brings invaluable experience ...
21/12/2023
December 20, 2023
Taming a plant-derived toxin Scripps Research team modifies the traditional poison picrotoxinin for potential neurological drugs and anti-parasite treatments. ...
19/12/2023
December 18, 2023
Scripps Research Executive Vice President Eric Topol gives TED talk on transformative power of AI in medicine Topol provides an overview of how AI models can i...
13/12/2023
December 12, 2023
New AI-powered algorithm could better assess people's risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke an...
07/12/2023
December 06, 2023
Nanoparticle flu vaccine design shows promise in early tests Scripps Research-designed vaccine could provide broad, enduring protection against influenza A str...
16/11/2023
November 15, 2023
Numerous Scripps Research scientists named Highly Cited Researchers Clarivate's annual, global list represents researchers who have demonstrated significant...